News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
92,934 Results
Type
Article (6755)
Company Profile (39)
Press Release (86140)
Section
Business (27748)
Career Advice (127)
Deals (4000)
Drug Delivery (32)
Drug Development (14134)
Employer Resources (12)
FDA (2856)
Job Trends (2111)
News (49278)
Policy (6014)
Tag
2024 BioForest Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
2026 Pharm Country Premier (1)
Academia (425)
Accelerated approval (2)
Adcomms (7)
Allergies (30)
Alliances (9009)
ALS (13)
Alzheimer's disease (260)
Antibody-drug conjugate (ADC) (39)
Approvals (2859)
Artificial intelligence (40)
Autoimmune disease (8)
Automation (3)
Bankruptcy (19)
Best Places to Work (1797)
BIOSECURE Act (16)
Biosimilars (74)
Biotechnology (26)
Bladder cancer (20)
Brain cancer (6)
Breast cancer (50)
Cancer (435)
Cardiovascular disease (20)
Career advice (110)
Career pathing (3)
CAR-T (20)
Cell therapy (83)
Cervical cancer (3)
Clinical research (11517)
Collaboration (181)
Compensation (40)
Complete response letters (9)
COVID-19 (545)
CRISPR (5)
C-suite (48)
Cystic fibrosis (13)
Data (413)
Denatured (2)
Depression (5)
Diabetes (35)
Diagnostics (557)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (23)
Drug pricing (22)
Drug shortages (1)
Duchenne muscular dystrophy (25)
Earnings (9483)
Editorial (5)
Employer branding (3)
Employer resources (10)
Events (11842)
Executive appointments (114)
FDA (3183)
Featured Employer (9)
Frontotemporal dementia (1)
Funding (141)
Gene editing (24)
Generative AI (5)
Gene therapy (79)
GLP-1 (107)
Government (1309)
Grass and pollen (1)
Guidances (11)
Healthcare (1957)
Huntington's disease (2)
IgA nephropathy (2)
Immunology and inflammation (37)
Indications (8)
Infectious disease (578)
Inflammatory bowel disease (46)
Inflation Reduction Act (4)
Influenza (15)
Intellectual property (11)
Interviews (11)
IPO (1840)
IRA (13)
Job creations (385)
Job search strategy (107)
Kidney cancer (2)
Labor market (2)
Layoffs (55)
Legal (560)
Liver cancer (13)
Lung cancer (73)
Lymphoma (25)
Management (2)
Manufacturing (99)
MASH (10)
Medical device (1170)
Medtech (1171)
Mergers & acquisitions (2251)
Metabolic disorders (82)
Multiple sclerosis (16)
NASH (2)
Neurodegenerative disease (18)
Neuropsychiatric disorders (1)
Neuroscience (332)
NextGen: Class of 2025 (697)
Non-profit (348)
Northern California (467)
Now hiring (10)
Obesity (30)
Opinion (45)
Ovarian cancer (20)
Pain (8)
Pancreatic cancer (13)
Parkinson's disease (9)
Partnered (3)
Patents (29)
Patient recruitment (19)
Peanut (21)
People (7988)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase I (3786)
Phase II (4790)
Phase III (4229)
Pipeline (283)
Podcasts (6)
Policy (40)
Postmarket research (297)
Preclinical (1478)
Press Release (66)
Prostate cancer (16)
Psychedelics (5)
Radiopharmaceuticals (37)
Rare diseases (69)
Real estate (915)
Recruiting (4)
Regulatory (4768)
Reports (11)
Research institute (387)
Resumes & cover letters (11)
RNA editing (1)
RSV (10)
Schizophrenia (11)
Series A (33)
Series B (13)
Service/supplier (3)
Sickle cell disease (7)
Southern California (468)
Special edition (3)
Spinal muscular atrophy (21)
Sponsored (9)
Startups (573)
State (1)
Stomach cancer (3)
Supply chain (9)
Tariffs (2)
The Weekly (4)
United States (3998)
Vaccines (183)
Venture capitalists (4)
Webinars (1)
Weight loss (14)
Women's health (3)
Date
Today (17)
Last 7 days (151)
Last 30 days (548)
Last 365 days (6361)
2025 (1647)
2024 (6528)
2023 (6963)
2022 (9060)
2021 (9479)
2020 (8176)
2019 (5871)
2018 (4526)
2017 (5071)
2016 (4635)
2015 (5295)
2014 (3721)
2013 (2897)
2012 (2990)
2011 (3147)
2010 (2576)
Location
Africa (92)
Alabama (11)
Alaska (1)
Arizona (12)
Arkansas (2)
Asia (7492)
Australia (881)
California (1102)
Canada (228)
China (167)
Colorado (32)
Connecticut (25)
Delaware (37)
Europe (13861)
Florida (128)
Georgia (18)
Idaho (13)
Illinois (46)
India (11)
Indiana (39)
Iowa (1)
Japan (27)
Kansas (3)
Kentucky (9)
Louisiana (2)
Maine (5)
Maryland (313)
Massachusetts (755)
Michigan (23)
Minnesota (45)
Mississippi (1)
Missouri (14)
Montana (5)
Nebraska (1)
Nevada (4)
New Hampshire (3)
New Jersey (438)
New Mexico (4)
New York (308)
North Carolina (193)
North Dakota (7)
Northern California (467)
Ohio (39)
Oklahoma (7)
Oregon (2)
Pennsylvania (185)
Puerto Rico (1)
Rhode Island (5)
South America (134)
South Carolina (2)
Southern California (468)
Tennessee (3)
Texas (143)
Utah (24)
Virginia (16)
Washington D.C. (6)
Washington State (87)
Wisconsin (7)
92,934 Results for "mtf biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MTF Biologics Appoints Donald Hackbarth and Sharon Gabrielson to Key Leadership Roles on Board of Directors
March 11, 2025
·
4 min read
Pharm Country
MTF Biologics and Centurion Therapeutics Partner to Expand Access to Advance Wound Care Technologies
MTF Biologics and Centurion Therapeutics announced they have entered into a new agreement that will give more clinicians and patients in complex wound settings within hospitals and post-acute care facilities access to advanced wound healing technologies.
June 13, 2024
·
4 min read
FDA
MTF Biologics® Receives First Investigational Device Exemption Approval for Human Acellular Dermal Matrix in Breast Reconstruction
MTF Biologics ® Receives First Investigational Device Exemption Approval for Human Acellular Dermal Matrix in Breast Reconstruction.
October 24, 2023
·
3 min read
Pharm Country
MTF Biologics Awards 2022 Extramural Research Grants
MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $850,000 in funding to seven researchers across the nation through its 2022 Extramural Research Grants Program.
January 11, 2023
·
3 min read
Pharm Country
MTF Biologics Unveils New Tissue Form: AlloPatch® Pliable Meshed - Acellular Human Reticular Dermal Allograft
MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, is introducing AlloPatch® Pliable Meshed to its line of premier, innovative and effective wound care solutions.
April 17, 2023
·
4 min read
Genetown
Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix
Bone Biologics Corporation announces it has entered into a supply agreement with MTF Biologics for demineralized bone matrix (DBM).
March 7, 2022
·
4 min read
Business
Orthofix and MTF Biologics Expand Partnership Agreement
Orthofix Medical Inc today announced the renewal and expansion of its partnership agreement with MTF Biologics – a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science.
May 3, 2022
·
6 min read
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Theriva™ Biologics to Present at the 2025 NeauxCancer Conference
March 20, 2025
·
2 min read
Press Releases
FairJourney Biologics Establishes Supervisory Board
March 25, 2025
·
4 min read
1 of 9,294
Next
